Madrigal Pharmaceuticals Files 2024 10-K
Ticker: MDGL · Form: 10-K · Filed: Feb 26, 2025 · CIK: 1157601
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
MDGL filed its 2024 10-K. All systems go for pharma prep.
AI Summary
Madrigal Pharmaceuticals, Inc. filed its 2024 10-K on February 26, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, previously known as Synta Pharmaceuticals Corp, is focused on pharmaceutical preparations. Key financial data and operational details for the period are outlined in the filing.
Why It Matters
This filing provides investors and analysts with a comprehensive overview of Madrigal Pharmaceuticals' financial health, strategic direction, and potential risks for the past fiscal year.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Madrigal Pharmaceuticals is subject to significant regulatory, clinical trial, and market risks inherent in drug development and commercialization.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (Comparison period for financial data)
- 2022 — Prior Fiscal Year (Comparison period for financial data)
Key Players & Entities
- MADRIGAL PHARMACEUTICALS, INC. (company) — Filer
- SYNTA PHARMACEUTICALS CORP (company) — Former Company Name
- 200 BARR HARBOR DRIVE, SUITE 400 (location) — Business and Mail Address
- WEST CONSHOHOCKEN, PA 19428 (location) — Business and Mail Address
- 404-380-9263 (phone_number) — Business Phone
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-26 (date) — Filing Date
FAQ
What is Madrigal Pharmaceuticals' primary business activity?
Madrigal Pharmaceuticals, Inc. is primarily involved in pharmaceutical preparations, as indicated by its SIC code [2834].
When was the company's fiscal year end?
The company's fiscal year ends on December 31st, as stated in the filing.
What was the filing date for this 10-K?
This 10-K filing was made on February 26, 2025.
Has Madrigal Pharmaceuticals operated under any other names?
Yes, the company was formerly known as Synta Pharmaceuticals Corp, with a name change date of August 15, 2001.
Where is Madrigal Pharmaceuticals headquartered?
The company's business and mail address is located at 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding MADRIGAL PHARMACEUTICALS, INC. (MDGL).